IBDEI02R ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3307,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3307,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,3307,1,5,0)
 ;;=5^Cml, W/O Remission
 ;;^UTILITY(U,$J,358.3,3307,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,3308,0)
 ;;=205.11^^26^285^44
 ;;^UTILITY(U,$J,358.3,3308,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3308,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,3308,1,5,0)
 ;;=5^Cml, In Remission
 ;;^UTILITY(U,$J,358.3,3308,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,3309,0)
 ;;=289.0^^26^285^49
 ;;^UTILITY(U,$J,358.3,3309,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3309,1,4,0)
 ;;=4^289.0
 ;;^UTILITY(U,$J,358.3,3309,1,5,0)
 ;;=5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,3309,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,3310,0)
 ;;=238.4^^26^285^101
 ;;^UTILITY(U,$J,358.3,3310,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3310,1,4,0)
 ;;=4^238.4
 ;;^UTILITY(U,$J,358.3,3310,1,5,0)
 ;;=5^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,3310,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,3311,0)
 ;;=V58.61^^26^285^122
 ;;^UTILITY(U,$J,358.3,3311,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3311,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,3311,1,5,0)
 ;;=5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,3311,2)
 ;;=Warfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,3312,0)
 ;;=282.49^^26^285^111
 ;;^UTILITY(U,$J,358.3,3312,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3312,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,3312,1,5,0)
 ;;=5^Thalassemia Nec
 ;;^UTILITY(U,$J,358.3,3312,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,3313,0)
 ;;=289.89^^26^285^15
 ;;^UTILITY(U,$J,358.3,3313,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3313,1,4,0)
 ;;=4^289.89
 ;;^UTILITY(U,$J,358.3,3313,1,5,0)
 ;;=5^Blood Diseases Nec
 ;;^UTILITY(U,$J,358.3,3313,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,3314,0)
 ;;=238.79^^26^285^82
 ;;^UTILITY(U,$J,358.3,3314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3314,1,4,0)
 ;;=4^238.79
 ;;^UTILITY(U,$J,358.3,3314,1,5,0)
 ;;=5^LYMPH/HEMATPOITC TIS NEC
 ;;^UTILITY(U,$J,358.3,3314,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,3315,0)
 ;;=287.30^^26^285^102
 ;;^UTILITY(U,$J,358.3,3315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3315,1,4,0)
 ;;=4^287.30
 ;;^UTILITY(U,$J,358.3,3315,1,5,0)
 ;;=5^Primary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,3315,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,3316,0)
 ;;=288.09^^26^285^2
 ;;^UTILITY(U,$J,358.3,3316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3316,1,4,0)
 ;;=4^288.09
 ;;^UTILITY(U,$J,358.3,3316,1,5,0)
 ;;=5^Agranulocytosis
 ;;^UTILITY(U,$J,358.3,3316,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,3317,0)
 ;;=V10.21^^26^285^55
 ;;^UTILITY(U,$J,358.3,3317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3317,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,3317,1,5,0)
 ;;=5^H/O Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,3317,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,3318,0)
 ;;=284.2^^26^285^98
 ;;^UTILITY(U,$J,358.3,3318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3318,1,4,0)
 ;;=4^284.2
 ;;^UTILITY(U,$J,358.3,3318,1,5,0)
 ;;=5^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,3318,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,3319,0)
 ;;=202.40^^26^285^68
 ;;^UTILITY(U,$J,358.3,3319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3319,1,4,0)
 ;;=4^202.40
 ;;^UTILITY(U,$J,358.3,3319,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspecified site
 ;;^UTILITY(U,$J,358.3,3319,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,3320,0)
 ;;=287.49^^26^285^113
 ;;^UTILITY(U,$J,358.3,3320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3320,1,4,0)
 ;;=4^287.49
 ;;^UTILITY(U,$J,358.3,3320,1,5,0)
 ;;=5^Thrombocytopenia,Drug Induced
 ;;^UTILITY(U,$J,358.3,3320,2)
 ;;=^339610
 ;;^UTILITY(U,$J,358.3,3321,0)
 ;;=285.9^^26^285^9
 ;;^UTILITY(U,$J,358.3,3321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3321,1,4,0)
 ;;=4^285.9
 ;;^UTILITY(U,$J,358.3,3321,1,5,0)
 ;;=5^Anemia NOS
 ;;^UTILITY(U,$J,358.3,3321,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,3322,0)
 ;;=287.9^^26^285^14
 ;;^UTILITY(U,$J,358.3,3322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3322,1,4,0)
 ;;=4^287.9
 ;;^UTILITY(U,$J,358.3,3322,1,5,0)
 ;;=5^Bleeding Disorder NOS
 ;;^UTILITY(U,$J,358.3,3322,2)
 ;;=^123920
 ;;^UTILITY(U,$J,358.3,3323,0)
 ;;=286.9^^26^285^46
 ;;^UTILITY(U,$J,358.3,3323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3323,1,4,0)
 ;;=4^286.9
 ;;^UTILITY(U,$J,358.3,3323,1,5,0)
 ;;=5^Coagulation Defect NOS
 ;;^UTILITY(U,$J,358.3,3323,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,3324,0)
 ;;=281.9^^26^285^48
 ;;^UTILITY(U,$J,358.3,3324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3324,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,3324,1,5,0)
 ;;=5^Deficiency Anemia NOS
 ;;^UTILITY(U,$J,358.3,3324,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,3325,0)
 ;;=280.9^^26^285^80
 ;;^UTILITY(U,$J,358.3,3325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3325,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,3325,1,5,0)
 ;;=5^Iron Deficiency Anemia NOS
 ;;^UTILITY(U,$J,358.3,3325,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,3326,0)
 ;;=287.5^^26^285^112
 ;;^UTILITY(U,$J,358.3,3326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3326,1,4,0)
 ;;=4^287.5
 ;;^UTILITY(U,$J,358.3,3326,1,5,0)
 ;;=5^Thrombocytopenia NOS
 ;;^UTILITY(U,$J,358.3,3326,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,3327,0)
 ;;=289.9^^26^285^114
 ;;^UTILITY(U,$J,358.3,3327,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3327,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,3327,1,5,0)
 ;;=5^Thrombocytosis NOS
 ;;^UTILITY(U,$J,358.3,3327,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,3328,0)
 ;;=195.0^^26^285^69
 ;;^UTILITY(U,$J,358.3,3328,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3328,1,4,0)
 ;;=4^195.0
 ;;^UTILITY(U,$J,358.3,3328,1,5,0)
 ;;=5^Head/Face/Neck CA
 ;;^UTILITY(U,$J,358.3,3328,2)
 ;;=^267306
 ;;^UTILITY(U,$J,358.3,3329,0)
 ;;=202.80^^26^285^84
 ;;^UTILITY(U,$J,358.3,3329,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3329,1,4,0)
 ;;=4^202.80
 ;;^UTILITY(U,$J,358.3,3329,1,5,0)
 ;;=5^Lymphoma NEC Unsp Site
 ;;^UTILITY(U,$J,358.3,3329,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,3330,0)
 ;;=193.^^26^285^118
 ;;^UTILITY(U,$J,358.3,3330,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3330,1,4,0)
 ;;=4^193.
 ;;^UTILITY(U,$J,358.3,3330,1,5,0)
 ;;=5^Thyroid CA
 ;;^UTILITY(U,$J,358.3,3330,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,3331,0)
 ;;=465.9^^26^286^69
 ;;^UTILITY(U,$J,358.3,3331,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3331,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,3331,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,3331,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,3332,0)
 ;;=462.^^26^286^60
 ;;^UTILITY(U,$J,358.3,3332,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3332,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,3332,1,5,0)
 ;;=5^Sore Throat
 ;;^UTILITY(U,$J,358.3,3332,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,3333,0)
 ;;=466.0^^26^286^3
 ;;^UTILITY(U,$J,358.3,3333,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3333,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,3333,1,5,0)
 ;;=5^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,3333,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,3334,0)
 ;;=112.1^^26^286^79
 ;;^UTILITY(U,$J,358.3,3334,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3334,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,3334,1,5,0)
 ;;=5^Vulvovaginitis,Candidal
 ;;^UTILITY(U,$J,358.3,3334,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,3335,0)
 ;;=616.0^^26^286^13
 ;;^UTILITY(U,$J,358.3,3335,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3335,1,4,0)
 ;;=4^616.0
 ;;^UTILITY(U,$J,358.3,3335,1,5,0)
 ;;=5^Cervicitis
 ;;^UTILITY(U,$J,358.3,3335,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,3336,0)
 ;;=599.0^^26^286^70
 ;;^UTILITY(U,$J,358.3,3336,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3336,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,3336,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,3336,2)
 ;;=UTI^124436
 ;;^UTILITY(U,$J,358.3,3337,0)
 ;;=460.^^26^286^46
 ;;^UTILITY(U,$J,358.3,3337,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3337,1,4,0)
 ;;=4^460.
 ;;^UTILITY(U,$J,358.3,3337,1,5,0)
 ;;=5^Nasopharyngitis, Acute
 ;;^UTILITY(U,$J,358.3,3337,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,3338,0)
 ;;=372.30^^26^286^14
 ;;^UTILITY(U,$J,358.3,3338,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3338,1,4,0)
 ;;=4^372.30
 ;;^UTILITY(U,$J,358.3,3338,1,5,0)
 ;;=5^Conjunctivitis
 ;;^UTILITY(U,$J,358.3,3338,2)
 ;;=^27546
 ;;^UTILITY(U,$J,358.3,3339,0)
 ;;=595.9^^26^286^15
 ;;^UTILITY(U,$J,358.3,3339,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3339,1,4,0)
 ;;=4^595.9
 ;;^UTILITY(U,$J,358.3,3339,1,5,0)
 ;;=5^Cystitis
 ;;^UTILITY(U,$J,358.3,3339,2)
 ;;=^30304
 ;;^UTILITY(U,$J,358.3,3340,0)
 ;;=110.1^^26^286^16
 ;;^UTILITY(U,$J,358.3,3340,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3340,1,4,0)
 ;;=4^110.1
 ;;^UTILITY(U,$J,358.3,3340,1,5,0)
 ;;=5^Dermatophytosis Nail
 ;;^UTILITY(U,$J,358.3,3340,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,3341,0)
 ;;=562.11^^26^286^17
 ;;^UTILITY(U,$J,358.3,3341,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3341,1,4,0)
 ;;=4^562.11
 ;;^UTILITY(U,$J,358.3,3341,1,5,0)
 ;;=5^Diverticulitis
 ;;^UTILITY(U,$J,358.3,3341,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,3342,0)
 ;;=424.90^^26^286^18
 ;;^UTILITY(U,$J,358.3,3342,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3342,1,4,0)
 ;;=4^424.90
 ;;^UTILITY(U,$J,358.3,3342,1,5,0)
 ;;=5^Endocarditis
 ;;^UTILITY(U,$J,358.3,3342,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,3343,0)
 ;;=604.90^^26^286^19
 ;;^UTILITY(U,$J,358.3,3343,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3343,1,4,0)
 ;;=4^604.90
 ;;^UTILITY(U,$J,358.3,3343,1,5,0)
 ;;=5^Epididymitis
 ;;^UTILITY(U,$J,358.3,3343,2)
 ;;=^86178
 ;;^UTILITY(U,$J,358.3,3344,0)
 ;;=707.15^^26^286^21
 ;;^UTILITY(U,$J,358.3,3344,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3344,1,4,0)
 ;;=4^707.15
 ;;^UTILITY(U,$J,358.3,3344,1,5,0)
 ;;=5^Foot Ulcer
 ;;^UTILITY(U,$J,358.3,3344,2)
 ;;=^322148
 ;;^UTILITY(U,$J,358.3,3345,0)
 ;;=558.9^^26^286^22
 ;;^UTILITY(U,$J,358.3,3345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3345,1,4,0)
 ;;=4^558.9
 ;;^UTILITY(U,$J,358.3,3345,1,5,0)
 ;;=5^Gastroenteritis
 ;;^UTILITY(U,$J,358.3,3345,2)
 ;;=^87311
